万维提示：
1、投稿方式：在线投稿。
2、期刊网址：http://www.jaapos.org/
https://www.journals.elsevier.com/journal-of-aapos
3、投稿网址：
https://www.editorialmanager.com/jaapos/default.aspx
4、官网邮箱：ME@jaapos.org（编辑部）
5、期刊刊期：双月刊，逢双月出版。
2021年6月4日星期五
投稿须知【官网信息】
Author Information
The Journal of AAPOS, the official publication of the American Association for Pediatric Ophthalmology and Strabismus, publishes clinical and laboratory investigations, current concept reviews, case reports, descriptions of instrumentation and surgical techniques, editorials, and correspondence on topics relevant to pediatric ophthalmology and strabismus. (Authors do not need to be members of the AAPOS, and manuscripts written by AAPOS members are not given preferential consideration.) Text or data previously published in a similar form or extensively reported in "tabloid" ophthalmological publications will not be considered. Questions pertaining to prior or simultaneous publication should be directed to the editor in chief (ME@jaapos.org) before the manuscript is submitted. Review articles, concept reviews (State of the Art), editorials, and AAPOS Workshops are generally submitted by invitation.
Types of paper
Major Articles
Short Reports
Reviews
AAPOS Workshops
Video Articles
Letters to the Editor
Editorials
Obituaries / News Items
Eye on the Arts / First Person / Clinical Pearls
Ethics in publishing
Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.
Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places: 1. A summary declaration of interest statement in the title page file (if double anonymized) or the manuscript file (if single anonymized). If there are no interests to declare then please state this: 'Declarations of interest: none'. 2. Detailed disclosures as part of a separate Declaration of Interest form, which forms part of the journal's official records. It is important for potential interests to be declared in both places and that the information matches. More information.
Declarations regarding IRB-HIPAA compliance should appear within the body of the paper. HIPAA should be spelled out e.g., this study was approved by the Institutional Review Board of [name of institution] and conformed to the requirements of the United States Health Insurance Portability and Privacy Act.
Submission declaration and verification
Submission of an article implies that the work described has not been published previously (except in the form of an abstract, a published lecture or academic thesis, see 'Multiple, redundant or concurrent publication' for more information), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder. To verify originality, your article may be checked by the originality detection service Crossref Similarity Check.
Use of inclusive language
Inclusive language acknowledges diversity, conveys respect to all people, is sensitive to differences, and promotes equal opportunities. Content should make no assumptions about the beliefs or commitments of any reader; contain nothing which might imply that one individual is superior to another on the grounds of age, gender, race, ethnicity, culture, sexual orientation, disability or health condition; and use inclusive language throughout. Authors should ensure that writing is free from bias, stereotypes, slang, reference to dominant culture and/or cultural assumptions. We advise to seek gender neutrality by using plural nouns ("clinicians, patients/clients") as default/wherever possible to avoid using "he, she," or "he/she." We recommend avoiding the use of descriptors that refer to personal attributes such as age, gender, race, ethnicity, culture, sexual orientation, disability or health condition unless they are relevant and valid. These guidelines are meant as a point of reference to help identify appropriate language but are by no means exhaustive or definitive.
Changes to authorship
Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.
Article transfer service
This journal is part of our Article Transfer Service. This means that if the Editor feels your article is more suitable in one of our other participating journals, then you may be asked to consider transferring the article to one of those. If you agree, your article will be transferred automatically on your behalf with no need to reformat. Please note that your article will be reviewed again by the new journal. More information.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (see more information on this). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations. If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases.
For gold open access articles: Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (more information). Permitted third party reuse of gold open access articles is determined by the author's choice of user license.
Author rights
As an author you (or your employer or institution) have certain rights to reuse your work. More information.
Elsevier supports responsible sharing
Find out how you can share your research published in Elsevier journals.
Role of the funding source
Identify sources of financial support for the research and/or preparation of the article and briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement, then this should be stated. Please see https://www.elsevier.com/funding.
Open access
Please visit our Open Access page for more information.
Language services
Please write your text in American English. Authors who feel their manuscript may require editing to eliminate grammatical and spelling errors or stylistic infelicities are encouraged to seek assistance from the English Language Editing service at Elsevier's WebShop https://webshop.elsevier.com/language-editing-services/language-editing/. Visit our customer support site https://service.elsevier.com for more information.
Informed consent and patient details
For reports or studies, excluding Short Reports, involving human subjects, a statement must appear early in the Methods section regarding Institutional Review Board (IRB) approval or waiver and when and from whom informed consent was obtained. For North American authors, the statement should indicate the name of the approving committee or body. For studies and reports from the United States, a declaration of compliance with HIPAA regulations should also be included. For studies from other areas, approval by an IRB is strongly encouraged. If IRB approval outside of North America is not available, the authors should confirm that the study and data collection conformed to all local laws and were compliant with the principles of the Declaration of Helsinki (JAMA 2000;284:3043-3045; http://jama.ama-assn.org/cgi/content/full/284/23/3043 ). Patients' names, initials, hospital or university numbers, dates and other potentially identifying information should not appear in the manuscript. For studies involving animals, where appropriate, approval by IRB or an equivalent body should be indicated in the Methods section.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer review process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by email.
Submit your article
All new manuscripts must be submitted in digital form through the Journal of AAPOS online submission and review Web site http://www.editorialmanager.com/jaapos/default.aspx.
Submission items include (as separate files):
Cover letter (for specific content of which, see below, "Authors' Responsibility")
Signed release forms for identifiable patients
Response to reviews (revised manuscripts only)
Title page (as a separate file for initial review but integrated into manuscript with revisions)
Manuscript (abstract, text, references, and figure legends), including continuous marginal line numbers, or "clean" revised manuscript (with all changes accepted)
Highlighted revision, with changes tracked and including continuous marginal line numbers (revised manuscripts only)
Tables
Figures. Clinical, radiological, and histopathological images should be cropped closely to the point(s) of interest, which may be further indicated by arrows and the like.
Video clips or e-supplements
Each page of the manuscript must include continuous line numbers in the margin. Files should be labeled with appropriate and descriptive file names (eg, Text.doc, Fig1.eps, Table3.doc). Upload text, tables, and graphics as separate files. A ".zip" file combining all files may also be used. Do not import figures or tables into the text document, and do not upload your text as a PDF file.
For initial review, a "masked" manuscript is required. Manuscript files, tables, figures, and electronic media should not contain the author's identities in the contents, header/footer, or file names.
Revised manuscripts must be submitted in two versions: a "clean" version, without highlighting or marginal callouts, and a second, "highlighted" version, with substantive changes tracked. Author name(s), institution(s), or the geographic location of the study masked for initial review may be unmasked in revision. Revised manuscripts must be accompanied by a separate file (distinct from the cover letter) with point-by-point responses to reviewers comments and indications of line numbers in the highlighted revision where changed text may be found. Note, it is not acceptable to simply reply to reviewers without also modifying the text accordingly; authors who decline to make a suggested revision must explain their reasoning.
The publisher and editors regret that they are not able to consider submissions that do not follow these procedures. Authors who are unable to provide electronic files or have other circumstances that prevent online submission may contact the editorial office prior to submission to discuss alternate options.
Referees
Please submit, with the manuscript, the names, addresses and email addresses of at least 2 potential referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
If a manuscript is returned to the author for revision, the revised version should be received by the Journal within 2 months. Otherwise, it will be considered a new submission.
In general, manuscripts should follow AMA Manual of Style (9th ed.) guidelines; technical terminology should reflect Dorland's Illustrated Medical Dictionary (30th ed.). Spelling must conform to U.S. English. Word processing software can assist with this task; in MS Word, for example, choose Tools, then Language, and Set Language: select English (U.S.). See also the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (http://www.icmje.org/).
Limit the use of abbreviations to those that are commonly understood without explanation (eg, mm Hg). Do not abbreviate a syndrome or term merely because it appears frequently in the manuscript. Pharmaceuticals should be referred to by the generic name. When brand names of equipment or other products are specified, the manufacturer and city and state of manufacture must be included in parentheses following first mention. Patients should be referred to by case number rather than by name or initials.
To mask author identity from reviewers, references to the author(s), institution(s), or geographic location(s) by name or initial should be masked from the manuscript until after initial peer review. If authors refer to their own previously published work, they may forgo masking that material. In such cases, authors should identify the issue in question in the cover letter. The editorial office can make a decision about whether or not to mask the material.
To enable the publisher to use your text files, please follow these instructions carefully. Do not justify the right margin or use centering tabs for text or headers. Be sure to key the letter O, the number 0, the letter l, and the number 1 correctly. Use only one space after colons or periods. Use the default hyphenation of your word processor. Use two hyphens for long dashes. Key in the reference list at the end of the text. Software designed to create references that is used as an adjunct to word processing software (eg, Endnote) may be used, but do not use your word processor's footnote or endnote feature to create such references. When preparing tables, use the table format or use only tabs, not spaces, to align columns. Text to be italicized or set in boldface in print may be keyboarded thus (italics may also be indicated by underlining). Do not input special typesetting codes. The publisher will handle all design considerations for typefaces and page layout.
Authors should make every effort to present Major Articles as concisely as possible. The Introduction generally need not exceed 2 paragraphs. Methods that require extensive detail may be supplemented with e-components. Discussions should focus on interpretation of the most salient features of the results. There is no need for a summary at the end of the manuscript.
Literature search
When making a statement such as "this is, to our knowledge, the first/only report of...," or providing a review of the published literature in a field, authors must demonstrate that they have conducted a comprehensive and systematic review of the literature. Methods of literature search and criteria for including/excluding articles much be stated directly in the manuscript in these cases. This paragraph, which should be placed at the end of the manuscript, before the reference list, under the heading "Literature Search," should state the databases and search terms used, years covered, and additional sources. (eg, articles cited in the reference lists of other articles). It should also indicate how the foreign literature was treated. Other databases such as ExerptaMedica/EMBASE (1947-present), Ophthalmic Literature (1947-1988),and Zentralblatt für die gesamte Ophthalmologie und ihre Grenzgebiete may include key articles that are not cited in MEDLINE.
Peer review
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written themselves or have been written by family members or colleagues or which relate to products or services in which the editor has an interest. Any such submission is subject to all of the journal's usual procedures, with peer review handled independently of the relevant editor and their research groups. More information on types of peer review.
Double anonymized review
This journal uses double anonymized review, which means the identities of the authors are concealed from the reviewers, and vice versa. More information is available on our website. To facilitate this, please include the following separately:
Title page (with author details): This should include the title, authors' names, affiliations, acknowledgements and any Declaration of Interest statement, and a complete address for the corresponding author including an e-mail address.
Anonymized manuscript (no author details): The main body of the paper (including the references, figures, tables and any acknowledgements) should not include any identifying information, such as the authors' names or affiliations.
Use of word processing software
……
更多详情：
https://www.jaapos.org/content/authorinfo
